Diabetes Prevalence and Its Relationship With Education, Wealth, and BMI in 29 Low- and Middle-Income Countries.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
04 2020
Historique:
received: 04 09 2019
accepted: 13 01 2020
pubmed: 14 2 2020
medline: 22 12 2020
entrez: 14 2 2020
Statut: ppublish

Résumé

Diabetes is a rapidly growing health problem in low- and middle-income countries (LMICs), but empirical data on its prevalence and relationship to socioeconomic status are scarce. We estimated diabetes prevalence and the subset with undiagnosed diabetes in 29 LMICs and evaluated the relationship of education, household wealth, and BMI with diabetes risk. We pooled individual-level data from 29 nationally representative surveys conducted between 2008 and 2016, totaling 588,574 participants aged ≥25 years. Diabetes prevalence and the subset with undiagnosed diabetes was calculated overall and by country, World Bank income group (WBIG), and geographic region. Multivariable Poisson regression models were used to estimate relative risk (RR). Overall, prevalence of diabetes in 29 LMICs was 7.5% (95% CI 7.1-8.0) and of undiagnosed diabetes 4.9% (4.6-5.3). Diabetes prevalence increased with increasing WBIG: countries with low-income economies (LICs) 6.7% (5.5-8.1), lower-middle-income economies (LMIs) 7.1% (6.6-7.6), and upper-middle-income economies (UMIs) 8.2% (7.5-9.0). Compared with no formal education, greater educational attainment was associated with an increased risk of diabetes across WBIGs, after adjusting for BMI (LICs RR 1.47 [95% CI 1.22-1.78], LMIs 1.14 [1.06-1.23], and UMIs 1.28 [1.02-1.61]). Among 29 LMICs, diabetes prevalence was substantial and increased with increasing WBIG. In contrast to the association seen in high-income countries, diabetes risk was highest among those with greater educational attainment, independent of BMI. LMICs included in this analysis may be at an advanced stage in the nutrition transition but with no reversal in the socioeconomic gradient of diabetes risk.

Identifiants

pubmed: 32051243
pii: dc19-1782
doi: 10.2337/dc19-1782
pmc: PMC7085810
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-775

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States
Organisme : NIDDK NIH HHS
ID : L30 DK122468
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007433
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007028
Pays : United States

Informations de copyright

© 2020 by the American Diabetes Association.

Références

World J Diabetes. 2014 Jun 15;5(3):296-304
pubmed: 24936251
Diabetologia. 2008 Nov;51(11):1971-9
pubmed: 18779946
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Obes Rev. 2013 Nov;14 Suppl 2:11-20
pubmed: 24102717
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Lancet. 2018 Aug 18;392(10147):607-609
pubmed: 29661480
Diabetologia. 2010 Dec;53(12):2538-45
pubmed: 20740271
PLoS One. 2015 May 05;10(5):e0124829
pubmed: 25942435
JAMA. 2004 Sep 8;292(10):1188-94
pubmed: 15353531
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240
pubmed: 30704950
Lancet Diabetes Endocrinol. 2016 Mar;4(3):197-198
pubmed: 26827114
J Diabetes Sci Technol. 2011 Jul 01;5(4):918-27
pubmed: 21880235
Public Health Nutr. 2002 Feb;5(1A):93-103
pubmed: 12027297
BMC Public Health. 2012 Jun 22;12:474
pubmed: 22726343
Diabetes Care. 2016 May;39(5):780-7
pubmed: 26965719
Int J Obes (Lond). 2008 Aug;32 Suppl 3:S56-9
pubmed: 18695655
J Natl Med Assoc. 2007 Sep;99(9):1013-23
pubmed: 17913111
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
Int J Epidemiol. 2012 Aug;41(4):1162-73
pubmed: 22736421
Int J Epidemiol. 2005 Dec;34(6):1274-81
pubmed: 16120636
Lancet. 2017 Jun 3;389(10085):2239-2251
pubmed: 28190580
Int J Epidemiol. 2012 Jun;41(3):871-86
pubmed: 22438428
Ann Intern Med. 2014 Apr 15;160(8):517-25
pubmed: 24733192
BMJ Open. 2018 Oct 15;8(10):e019775
pubmed: 30327395
BMJ Open. 2017 Apr 17;7(4):e013569
pubmed: 28420660
Diabetes Care. 2004 Mar;27(3):716-21
pubmed: 14988291
Int J Epidemiol. 2011 Jun;40(3):804-18
pubmed: 21335614
Clin Chem. 2002 Mar;48(3):436-72
pubmed: 11861436
Epidemiol Rev. 2004;26:63-77
pubmed: 15234948
J Glob Health. 2018 Dec;8(2):020409
pubmed: 30140435

Auteurs

Jacqueline A Seiglie (JA)

Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA jseiglie@partners.org.
Department of Medicine, Harvard Medical School, Boston, MA.

Maja-Emilia Marcus (ME)

Department of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.

Cara Ebert (C)

Department of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.

Nikolaos Prodromidis (N)

Department of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.

Pascal Geldsetzer (P)

Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA.

Michaela Theilmann (M)

Institute of Global Health, Heidelberg University, Heidelberg, Germany.

Kokou Agoudavi (K)

Ministry of Health, Lome, Togo.

Glennis Andall-Brereton (G)

Non-Communicable Diseases, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.

Krishna K Aryal (KK)

Nepal Health Research Council, Kathmandu, Nepal.

Brice Wilfried Bicaba (BW)

Institut Africain de Santé publique, Ouagadougou, Burkina Faso.

Pascal Bovet (P)

Ministry of Health, Victoria, Republic of Seychelles.
University Center for Primary Care and Public Health, Lausanne, Switzerland.

Garry Brian (G)

The Fred Hollows Foundation NZ, Auckland, New Zealand.

Maria Dorobantu (M)

Cardiology Department, Emergency Hospital of Bucharest, Bucharest, Romania.

Gladwell Gathecha (G)

Division of Non-Communicable Diseases, Kenya Ministry of Health, Nairobi, Kenya.

Mongal Singh Gurung (MS)

Health Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan.

David Guwatudde (D)

Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda.

Mohamed Msaidié (M)

Comoros Ministry of Health, Solidarity, Social Cohesion and Gender, Moroni, Comoros.

Corine Houehanou (C)

Laboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.

Dismand Houinato (D)

Laboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.

Jutta Mari Adelin Jorgensen (JMA)

Partners In Health, Boston, MA.

Gibson B Kagaruki (GB)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Khem B Karki (KB)

Department of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.

Demetre Labadarios (D)

Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.

Joao S Martins (JS)

Faculty of Medicine and Health Sciences, National University of East Timor, Dili, Timor-Leste.

Mary T Mayige (MT)

National Institute for Medical Research, Dar es Salaam, Tanzania.

Roy Wong-McClure (R)

Epidemiology Office and Surveillance, Caja Costarricense de Seguro Social, San Jose, Costa Rica.

Joseph Kibachio Mwangi (JK)

Division of Non-Communicable Diseases, Kenya Ministry of Health, Nairobi, Kenya.
Faculté de médecine, Université de Genève, Geneva, Switzerland.

Omar Mwalim (O)

Zanzibar Ministry of Health, Mnazi Mmoja, Zanzibar.

Bolormaa Norov (B)

National Center for Public Health, Ulaanbaatar, Mongolia.

Sarah Quesnel-Crooks (S)

Non-Communicable Diseases, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.

Bahendeka K Silver (BK)

St. Francis Hospital, Nsambya, Kampala, Uganda.

Lela Sturua (L)

Non-Communicable Disease Department, National Center for Disease Control and Public Health, Tbilisi, Georgia.

Lindiwe Tsabedze (L)

Swaziland Ministry of Health, Mbabane, Swaziland.

Chea Stanford Wesseh (CS)

Liberia Ministry of Health, Monrovia, Liberia.

Andrew Stokes (A)

Center for Global Health and Development, Boston University, Boston, MA.

Rifat Atun (R)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.
Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, MA.

Justine I Davies (JI)

MRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
Institute of Applied Health Research, University of Birmingham, Birmingham, U.K.

Sebastian Vollmer (S)

Department of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.

Till W Bärnighausen (TW)

Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.
Africa Health Research Institute, Somkhele, South Africa.

Lindsay M Jaacks (LM)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.
Public Health Foundation of India, New Delhi, India.

James B Meigs (JB)

Department of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Deborah J Wexler (DJ)

Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Medicine, Harvard Medical School, Boston, MA.

Jennifer Manne-Goehler (J)

Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH